Description

This study focuses on the Chinese active pharmaceutical ingredients(APIs) in healthcare market, examining drivers and restraints for growth, pricing, technology, legislation, demand and geographical trends. Following this, the growth for market segments is forecasted. In addition, an in-depth analysis of the competitive situation has been provided. The market is further divided into two sub segments including synthetic APIs and biotech APIs. The study also provides an analysis of the market on customer base including generic APIs and innovative APIs.